Versions of Massachusetts General Laws ch. 94C sec. 6A - Licensure of certain corporate entities with patients receiving opioid agonist therapy; best practice guidance for practitioners on LawServer 2023 Massachusetts General Laws ch. 94C sec. 6A – Licensure of certain corporate entities with patients receiving opioid agonist therapy; best practice guidance for practitioners 2022 Massachusetts General Laws ch. 94C sec. 6A – Licensure of certain corporate entities with patients receiving opioid agonist therapy; best practice guidance for practitioners 2020 Massachusetts General Laws ch. 94C sec. 6A – Licensure of certain corporate entities with patients receiving opioid agonist therapy; best practice guidance for practitioners 2019 Massachusetts General Laws ch. 94C sec. 6A – Licensure of certain corporate entities with patients receiving opioid agonist therapy; best practice guidance for practitioners 2017 Massachusetts General Laws ch. 94C sec. 6A – Licensure of certain corporate entities with patients receiving opioid agonist therapy; best practice guidance for practitioners 2016 Massachusetts General Laws ch. 94C sec. 6A – Licensure of certain corporate entities with patients receiving opioid agonist therapy; best practice guidance for practitioners 2015 Massachusetts General Laws ch. 94C sec. 6A – Licensure of certain corporate entities with patients receiving opioid agonist therapy; best practice guidance for practitioners